Polo-like Kinase 2 Promotes Microglial Activation Via Regulation of the HSP90a/IKKR a /IKK R Pathway

Junjie Cheng,Lei Wu,Xiaowan Chen,Shuai Li,Renjuan Sun,Yiwei Huang,Peng Wang,Jiawei Ouyang,Panpan Pei,Huicui Yang,Guanghui Wang,Xuechu Zhen,Long-Tai Zheng
DOI: https://doi.org/10.1016/j.celrep.2024.114827
IF: 8.8
2024-01-01
Cell Reports
Abstract:Polo-like kinase 2 (PLK2) is a serine/threonine protein kinase associated with the regulation of synaptic plasticity and centriole duplication. We identify PLK2 as a crucial early-response gene in lipopolysaccharide (LPS)-stimulated microglial cells. Knockdown or inhibition of PLK2 remarkably attenuates LPS-induced expression of proinflammatory factors in microglial cells by suppressing the inhibitor of nuclear factor kappa B kinase subunit beta (IKKR)-nuclear factor (NF)-kB signaling pathway. We identify heat shock protein 90 alpha (HSP90a), a regulator of IKKR activity, as a novel PLK2 substrate. Knockdown or pharmacological inhibition of HSP90a abolishes PLK2-mediated activation of NF-kB transcriptional activity and microglial inflammatory activation. Furthermore, phosphoproteomic analysis pinpoints Ser252 and Ser263 on HSP90a as novel phosphorylation targets of PLK2. Lastly, conditional knockout of PLK2 in microglial cells dramatically ameliorates neuroinflammation and subsequent dopaminergic neuron loss in an intracranial LPSinduced mouse Parkinson's disease (PD) model. The present study reveals that PLK2 promotes microglial activation through the phosphorylation of HSP90a and subsequent activation of the IKKR-NF-kB signaling pathway.
What problem does this paper attempt to address?